J. Molner AS Logo

J. Molner AS

A CDRO specializing in generic injectable and topical drugs for the North American market.

JML | Nasdaq Baltic

Overview

Corporate Details

ISIN(s):
EE3100109034
LEI:
984500F0KEF52E642E45
Country:
Estonia
Address:
Akadeemia tee 21/5, 12618 Tallinn
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

J. Molner AS is a pharmaceutical contract development and research organization (CDRO) that specializes in generic drug development. The company's core expertise is focused on sterile injectable and dermatology (topical) drugs. It provides a range of services to the global pharmaceutical industry, including analytical chemistry, formulation development, and commercial stability solutions. Originally founded in Estonia in 2015, the company primarily serves clients in the U.S. and Canadian markets, aiming to make generic drugs and topical formulations more accessible.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all J. Molner AS filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for J. Molner AS via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Israel TMIS
THERACRYF PLC Logo
Developing sulforaphane-based therapeutics for oncology and behavioural brain disorders.
United Kingdom TCF
Toleranzia AB Logo
Developing immune therapies for rare autoimmune diseases like myasthenia gravis.
Sweden TOL
UCAR Logo
A nonprofit consortium managing atmospheric research and providing resources to the scientific community.
France ALUCR
VERICI DX PLC Logo
AI-powered diagnostic tests for the kidney transplant market, predicting organ rejection and injury.
United Kingdom VRCI
Vicore Pharma Holding Logo
Develops AT2 receptor drugs and a digital therapeutic for pulmonary fibrosis.
Sweden VICO
R&D in renewable energy & manufacturing specialized tools for automotive & engineering.
Slovakia N/A
Xlife Sciences AG Logo
A life sciences incubator commercializing early-stage academic research for healthcare markets.
Switzerland XLS
Yoshi Innovation Spolka Akcyjna Logo
A tech fund incubating MedTech, biotech, and defense ventures with investment and IP protection.
Poland YOS

Talk to a Data Expert

Have a question? We'll get back to you promptly.